Skip to main content
. 2024 Nov 20;12(12):e1954–e1961. doi: 10.1016/S2214-109X(24)00378-4

Figure 2.

Figure 2

Percentage reductions in antibiotic use of any drug class for nine enteric pathogen vaccine scenarios compared with the no vaccine scenario with 60% full vaccine efficacies against severe cause-specific diarrhoea at five sites in the MAL-ED birth cohort study

ETEC=enterotoxigenic Escherichia coli.